Subscribe to RSS
DOI: 10.1055/s-0030-1261784
An Overview of Image-Guided Percutaneous Ablation of Renal Tumors
Publication History
Publication Date:
20 August 2010 (online)

ABSTRACT
Although nephron-sparing surgery remains the gold standard treatment for small renal tumors, minimally invasive image-guided percutaneous ablation is becoming a viable alternative to operative resection. Percutaneous radiofrequency ablation (RFA) and cryoablation show high technical success rates, a relatively low incidence of residual or recurrent tumor, and competitive rates of patient survival. In this review, an overview of the current status of image-guided percutaneous ablation of renal tumors is presented, with a focus on procedure indications and patient selection, technical aspects of ablation procedures, and treatment outcomes and patient follow-up.
KEYWORDS
Percutaneous - ablation - radiofrequency - cryoablation - kidney - renal - tumor
REFERENCES
- 1 Chow W H, Devesa S S, Warren J L, Fraumeni Jr J F. Rising incidence of renal cell cancer in the United States. JAMA. 1999; 281 1628-1631
- 2 Pantuck A J, Zisman A, Belldegrun A S. The changing natural history of renal cell carcinoma. J Urol. 2001; 166 1611-1623
- 3 American Cancer Society .Cancer Statistics 2008. Atlanta, GA; American Cancer Society 2008
- 4 Luciani L G, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982–1997). Urology. 2000; 56 58-62
- 5 Janzen N K, Kim H L, Figlin R A et al.. Surveillance after radical or nephron sparing surgery for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003; 30 843-852
- 6 Fergany A F, Hafez K S, Novick A C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow up. J Urol. 2000; 163 442-445
- 7 Gill I S, Kavoussi L R, Lane B R et al.. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007; 178 41-46
- 8 Breda A, Finelli A, Janetschek G, Porpiglia F, Montorsi F. Complications of laparoscopic surgery for renal masses: prevention, management, and comparison with the open experience. Eur Urol. 2009; 55 836-850
- 9 Spaliviero M, Moinzadeh A, Gill I S. Laparoscopic cryotherapy for renal tumors. Technol Cancer Res Treat. 2004; 3 177-180
- 10 Hui G C, Tuncali K, Tatli S, Morrison P R, Silverman S G. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol. 2008; 19 1311-1320
- 11 Gervais D A, McGovern F J, Wood B J et al.. Radiofrequency ablation of renal cell carcinoma: early clinical experience. Radiology. 2000; 217 665-672
- 12 Atwell T D, Farrell M A, Leibovich B C et al.. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008; 179 2136-2141
- 13 Maybody M, Solomon S B. Image-guided percutaneous cryoablation of renal tumors. Tech Vasc Interv Radiol. 2007; 10 140-148
- 14 Boss A, Clasen S, Kuczyk M et al.. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol. 2005; 40 583-590
- 15 Miki K, Shimomura T, Yamada H et al.. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Int J Urol. 2006; 13 880-884
- 16 Farrell M A, Charboneau J W, Callstrom M R et al.. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003; 181 1315-1317
- 17 Kam A W, Littrup P J, Walther M M et al.. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol. 2004; 15 753-758
- 18 Gervais D A, Arellano R S, McGovern F J, McDougal W S, Mueller P R. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am J Roentgenol. 2005; 185 72-80
- 19 Cantwell C P, Wah T M, Gervais D A et al.. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008; 19 1034-1040
- 20 Park B K, Kim C K. Using an electrode as a lever to increase the distance between renal cell carcinoma and bowel during CT-guided radiofrequency ablation. Eur Radiol. 2008; 18 743-746
- 21 Allaf M E, Varkarakis I M, Bhayani S B et al.. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation – initial observations. Radiology. 2005; 237 366-370
- 22 Littrup P J, Ahmed A, Aoun H D et al.. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007; 18 383-392
- 23 Solomon S B, Chan D Y, Jarrett T W. Percutaneous cryotherapy of kidney tumors. Am J Urol Rev. 2004; 2 369-371
- 24 Silverman S G, Tuncali K, van Sonnenberg E et al.. Renal tumors MR imaging-guided percutaneous cryotherapy – initial experience in 23 patients. Radiology. 2005; 236 716-724
- 25 Gill I S, Novick A C, Meraney A M et al.. Laparoscopic renal cryoablation in 32 patients. Urology. 2000; 56 748-753
- 26 Matin S F, Ahrar K, Cadeddu J A et al.. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006; 176 1973-1977
- 27 Permpongkosol S, Nicol T L, Link R E et al.. Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol. AJR Am J Roentgenol. 2007; 188 1028-1032
- 28 Gervais D A, McGovern F J, Arellano R S, McDougal W S, Mueller P R. Radiofrequency ablation of renal cell carcinoma. Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005; 185 64-71
- 29 McDougal W S, Gervais D A, McGovern F J, Mueller P R. Long-term follow-up of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol. 2005; 174 61-63
- 30 Simon C J, Dupuy D E, Mayo-Smith W W. Microwave ablation: principles and applications. Radiographics. 2005; 25 S69-S83
- 31 Dick E A, Joarder R, De Jode M G, Wragg P, Vale J A, Gedroyc W M. Magnetic resonance imaging-guided laser thermal ablation of renal tumours. BJU Int. 2002; 90(9) 814-822
- 32 Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality: clinical implications. Technol Cancer Res Treat. 2007; 6 37-48
- 33 Marberger M, Schatzl G, Kranston D, Kennedy J E. Extracorporeal ablation of renal tumors with high intensity focused ultrasound. BJU Int. 2005; 95 52-55
- 34 Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol. 2009; 19 188-191
- 35 Johnson D B, Solomon S B, Su L M et al.. Defining the complications of cryoablation and radiofrequency ablation of small renal tumors: a multi-institutional review. J Urol. 2004; 172 874-877
- 36 Smith S, Gillams A. Imaging appearances following thermal ablation. Clin Radiol. 2008; 63 1-11
- 37 Merkle E M, Nour S G, Lewin J S. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology. 2005; 235 1065-1071
- 38 Uppot R N, Silverman S G, Zagoria R J, Tuncali K, Childs D D, Gervais D A. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol. 2009; 192 1558-1570
- 39 Kawamoto S, Solomon S B, Bluemke D A, Fishman E K. Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation. Semin Ultrasound CT MR. 2009; 30 67-77
- 40 Gill I S, Remer E M, Hasan W A et al.. Renal cryoablation: outcome at 3 years. J Urol. 2005; 173 1903-1907
- 41 Janzen N K, Perry K T, Han K R et al.. The effects of intentional cryoablation and radiofrequency ablation of renal tissue involving the collecting system in a porcine model. J Urol. 2005; 173 1368-1374
Majid MaybodyM.D.
Section of Interventional Radiology, Department of Radiology, Memorial Sloan-Kettering Cancer Center
1275 York Avenue, H118A New York, NY 10065
Email: maybodym@mskcc.org